Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2, 6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adducts

https://doi.org/10.1016/0003-9861(87)90365-1Get rights and content

Abstract

Administration of 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine (DDEP) (a structural analog of the dihydropyridine Ca2+ antagonists) to untreated, phenobarbital-, or dexamethasone-pretreated rats results in time-dependent losses of hepatic cytochrome P-450 content. Functional markers for various cytochrome P-450 isozymes have permitted the identification of P-450h, P-450 PB-1/k, and P-450p as the isozymes inactivated preferentially by the drug. DDEP-mediated cytochrome P-450 destruction may be reproduced in vitro, is most prominent after pretreatment of rats with dexamethasone, pregnenolone 16α-carbonitrile or phenobarbital, and is blocked by triacetyloleandomycin. These findings together with the observation that DDEP markedly inactivates hepatic 2β- and 6β-testosterone hydroxylase and erythromycin N-demethylase tend to indict the steroid-inducible P-450p isozyme as a key protagonist in this event. The precise mechanism of such DDEP-mediated P-450p heme destruction is unclear, but involves prosthetic heme alkylation of the apocytochrome at its active site in what appears to be a novel mechanism-based “suicide” inactivation. Such inactivation appears to involve fragmentation of the heme to reactive metabolites that irreversibly bind to the protein, but the chemical structure of the heme-protein adducts is yet to be established. Intriguingly, such DDEP-mediated P-450p destruction in vivo also results in accelerated loss of immunochemically detectable apocytochrome P-450p. It remains to be determined whether or not this loss is due to enhanced proteolysis triggered by the structural modification of the apocytochrome.

References (41)

  • P.R. Ortiz de Montellano et al.

    J. Biol. Chem

    (1981)
  • F. De Matteis et al.

    FEBS Lett

    (1981)
  • F.P. Guengerich

    Biochem. Biophys. Res. Commun

    (1986)
  • H.S. Da vies et al.

    Biochem. Pharmacol

    (1985)
  • H.S. Davies et al.

    Arch. Biochem. Biophys

    (1986)
  • H.S. Davies et al.

    Chem. Biol. Interact

    (1986)
  • C. Decker et al.

    Biochem. Biophys. Res. Commun

    (1986)
  • O.H. Lowry et al.

    J. Biol. Chem

    (1951)
  • K. Comai et al.

    J. Biol. Chem

    (1973)
  • M.A. Correia et al.

    J. Biol. Chem

    (1978)
  • R.A. Lubet et al.

    Arch. Biochem. Biophys

    (1985)
  • D.J. Waxman et al.

    J. Biol. Chem

    (1983)
  • F.P. Guengerich et al.

    J. Biol. Chem

    (1986)
  • O. Augusto et al.

    J. Biol. Chem

    (1982)
  • J.C. Docherty et al.

    Arch. Biochem. Biophys

    (1984)
  • L. Cantoni et al.

    Int. J. Biochem

    (1981)
  • B.C. Finzel et al.

    J. Biol. Chem

    (1984)
  • T.M. Florence

    J. Inorg. Biochem

    (1985)
  • R.H. Rice et al.

    Arch. Biochem. Biophys

    (1983)
  • P.R. Ortiz de Montellano et al.

    Biochem. Biophys. Res. Commun

    (1981)
  • Cited by (79)

    • Ubiquitin-dependent proteasomal degradation of human liver cytochrome P450 2E1: Identification of sites targeted for phosphorylation and ubiquitination

      2011, Journal of Biological Chemistry
      Citation Excerpt :

      However, it is now increasingly evident that in common with other type I monotopic ER proteins, P450s such as CYPs 3A (both native and structurally inactivated) undergo ER-associated degradation (ERAD) involving the ubiquitin (Ub)-dependent 26 S proteasomal system (UPS) (6–9, 12–16). This process entails the ubiquitination of the predominantly cytosol (C)-localized monotopic ER proteins by an E2 Ub-conjugating enzyme (Ubc)-E3 Ub ligase complex, its concurrent extraction from the ER membrane by the p97-AAA ATPase, and its delivery to the 26 S proteasome (12–17, 39, 40). CYPs 3A thus may qualify as typical ERAD-C substrates.

    • Liver Cytochrome P450 3A endoplasmic reticulum-associated degradation: A major role for the P97 AAA ATPase in cytochrome P450 3A extraction into the cytosol

      2011, Journal of Biological Chemistry
      Citation Excerpt :

      We therefore infer by analogy to yeast that in rat hepatocytes, an intact functional p97-Npl4-Ufd1 complex is similarly involved in the delivery of ER-anchored CYP3A to the cytosolic 26 S proteasome for its subsequent degradation and that this process too is also critically dependent on ATP-derived energy. Taken together with our previously published findings (11–17), the present findings underscore that both the native and DDEP-inactivated CYP3A species are genuine ERAD-C substrates, subscribing to all of the requisite criteria of an ERAD-C process (29–31). The findings above also reveal that CYP3A ubiquitination occurs to a substantial degree in the ER while the P450 protein is still tethered to the ER membrane.

    • Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: Physiological and pharmacological relevance

      2010, Journal of Biological Chemistry
      Citation Excerpt :

      Using various in vivo and in vitro reconstituted eukaryotic systems, we have shown that both native3 and structurally inactivated CYPs 3A incur ubiquitin (Ub)-dependent proteasomal degradation (UPD), in a typical ER-associated degradation (ERAD) process involving phosphorylation, ubiquitination, ER membrane extraction into the cytosol, and subsequent degradation by the 26S proteasome (2–13). Indeed mechanism-based CYP3A inactivation often results in active site structural lesions within their cytosolic domain (2, 6, 7), thereby qualifying these proteins as bona fide ERAD-C substrates. The pathways of P450 degradation appear to be highly conserved in all eukaryotes from yeast to man (11–22).

    • A role for protein phosphorylation in cytochrome P450 3A4 ubiquitin-dependent proteasomal degradation

      2009, Journal of Biological Chemistry
      Citation Excerpt :

      However, the relative rate of this degradation is considerably increased after CYP3A inactivation (2, 3, 6). Indeed, CYP3A suicide inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine, the agent employed in our previous studies (2, 3, 6, 68), and that by CuOOH or H2O2 is mechanistically very similar, involving oxidative fragmentation of the heme to reactive products that irreversibly bind to the P450 active site (49, 69, 70). This structural insult damages the P450 protein, marking it for ubiquitination and thus rapid clearance via UPD (2, 3, 6, 7, 68).

    • Ubiquitination of neuronal nitric-oxide synthase in vitro and in vivo

      2000, Journal of Biological Chemistry
      Citation Excerpt :

      These observations are consistent with the finding that liver microsomal P450 cytochromes, which are heme-thiolate enzymes similar to NOS, are ubiquitinated and proteasomally degraded after suicide inactivation (23, 24). In the case of suicide inactivation of liver P450 cytochromes, structural changes and not the functional inactivation per se appears to be the “trigger” for proteolysis (25, 26). In particular, the cross-linking of heme to the protein, which occurs during suicide inactivation of cytochrome P450, plays a prominent role in the enhanced turnover of cytochrome P450 (23-25, 27).

    View all citing articles on Scopus
    View full text